Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT).
Brahmi M, Cassier P, Dufresne A, Chabaud S, Karanian M, Meurgey A, Bouhamama A, Gouin F, Vaz G, Garret J, Sunyach MP, Dupré A, Marec-Berard P, Corradini N, Perol D, Ray-Coquard I, Blay JY.
Brahmi M, et al.
PLoS One. 2020 May 20;15(5):e0233046. doi: 10.1371/journal.pone.0233046. eCollection 2020.
PLoS One. 2020.
PMID: 32433669
Free PMC article.